Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal CarcinomaHuichao Huang, Yongheng Chen|Pharmaceuticals|2022Cited by 84
Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatmentMaojun Zhou, Yongheng Chen, Yubin Li et al.|Aging|2021Cited by 21
Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative PhosphoproteomicsHuichao Huang, Yongheng Chen|Frontiers in Cell and Developmental Biology|2020Cited by 16
Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphoproteome, and Acetylome in Nasopharyngeal Carcinoma CellsHuichao Huang, Yongheng Chen|Frontiers in Genetics|2022Cited by 6